Published Date: 08 Mar 2023
While some say this strategy's failure rate is "too high," it's one step closer to the "white grail" of a shorter 24-week formula.
Read Full NewsA prostate cancer diagnosis and life during and after treatments can feel overwhelming. Alongside the shock of a diagnosis, you may be faced with multiple treatment options and asked to make a choice—surgery, radiation ...
Neuroblastoma remains one of the deadliest childhood malignancies, accounting for a disproportionate number of pediatric cancer deaths worldwide.
1.
In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.
2.
FAPI PET/CT enhances the staging of recently discovered breast cancer, according to comparative analysis.
3.
Glioblastoma treatment breakthrough shows promise
4.
Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLC
5.
Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.
1.
Understanding Hidrocystoma: Symptoms, Causes, and Treatment Options
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer
4.
Value, Access, and Affordability in Next-Gen Oncology: Navigating Costs, Coverage, and Clinical Impact
5.
Unlocking the Potential of Leukemia Treatment: A New Hope for Patients
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Updates on the First Line Management of ALK+ NSCLC
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation